Skip to main content
Caplight Logo









Therakind Ltd

Therakind Ltd

Private
LondonHealthcare & Life Scienceshttps://www.therakind.com/

Last Round

Grant

Jun 1, 2024

Est. Valuation

$1.21M

Total Funding Raised

$740,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Therakind Ltd is a specialty pharmaceutical company that develops niche medicines and proprietary drug-device combinations, including its DriDose® intranasal dry powder delivery platform, to improve patient adherence and drug delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

specialty pharmaceuticalsdrug delivery deviceintranasal deliverydrug-device combinationpediatric medicinegeriatric medicinedrug delivery techmedication adherenceniche pharmaformulation developmentneedle-free injectiondrug licensingregulatory strategypharma co-developmentpatient-friendly dosing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Therakind Ltd Comparables

Compare Therakind Ltd with similar companies based on industry and business-model similarity.

Therakind Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeteo Biomedical
86%
Rhinal Therapeutics
79%
Shin Nippon Biomedical Laboratories Ltd
74%

Therakind Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2024
Buyout/LBOMar 25, 2024
SeedJul 11, 2007

Key People

Founding team and executive leadership

Samantha Race

Chief Financial Officer

Executive Team

Louise Rawcliffe

Chief Operating Officer

Executive Team

Therakind Ltd Investors

Notable investors and investment history

Therakind Ltd investors
InvestorRounds
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 2237% MoM, reaching 958.

  • Mar 25, 2024

    Completed a buyout/LBO round.

Therakind Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Therakind Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Therakind Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2006
Last FundingJun 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?